Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03567421 · ClinicalTrials.gov registry record
Ureteral Stenting After Ureteroscopy for Stone Treatment, A Global Perspective on Indications and Outcomes
A clinical trial, sponsored by Société Internationale d'Urologie.
- Completed
- Registry status
- 2,348
- Enrollment target
NCT03567421 is a clinical trial that has completed, run by Société Internationale d'Urologie. The registered enrollment target is 2,348 participants.
The verdict
NCT03567421 has completed, sponsored by Société Internationale d'Urologie.
- COMPLETED
- Registry status
- 2,348 participants
- Enrollment target
Study Summary
Background: The exit strategy after ureteroscopy for stone treatment remains a topic for discussion. Current EAU guidelines on urolithiasis state that postoperative stenting is indicated in patients at increased risk of postoperative complications. Stenting is not considered necessary in all other cases, and after uncomplicated procedures. Objective: To analyse the postoperative ureteral stenting strategy in clinical practice looking at the indication, type of stents used and the duration of stenting after ureteroscopy for stone treatment. Furthermore, the investigators will examine in what setting the stents are being removed postoperatively. Study design: This study is a prospective, observational, international, multicentre registry study executed by uCARE. Study population: All patients \>18 years with a ureter or renal stone who are planned for ureteroscopic treatment by semi-rigid and/or flexible ureteroscopy are eligible for this study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,348 participants |
| Start Date | 2018-06-07 |
| Est. Completion | 2019-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03567421
The ClinicalTrials.gov registry entry for NCT03567421 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,348 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Société Internationale d'Urologie, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03567421 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03567421 about?
NCT03567421 is a clinical study titled "Ureteral Stenting After Ureteroscopy for Stone Treatment, A Global Perspective on Indications and Outcomes". Background: The exit strategy after ureteroscopy for stone treatment remains a topic for discussion. Current EAU guidelines on urolithiasis state that postoperative stenting is indicated in patients at increased risk of postoperative complications. Stenting is not considered necessary in all other c...
What is the current status of trial NCT03567421?
This trial is currently completed. The enrollment target is 2,348 participants. The study started on 2018-06-07. Estimated completion is 2019-08-31.
Who is sponsoring clinical trial NCT03567421?
This trial is sponsored by Société Internationale d'Urologie, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.